Marie Jeanne Mayaux

Summary

Country: France

Publications

  1. ncbi Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort
    Marie Jeanne Mayaux
    INSERM U569, Hopital de Bicetre, 82 rue du General Leclerc, 94276 Le Kremlin Bicetre Cedex, Paris, France
    J Acquir Immune Defic Syndr 34:338-43. 2003
  2. ncbi Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1
    Albert Faye
    Pediatrie Generale, hôpital R Debré, Paris, France
    Clin Infect Dis 39:1692-8. 2004
  3. ncbi Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants
    Albert Faye
    Service d Hémato immunologie, Hĵpital R Debré, Paris, France
    Pediatr Infect Dis J 21:518-25. 2002
  4. ncbi Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis
    John P A Ioannidis
    Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
    AIDS 18:99-108. 2004

Detail Information

Publications4

  1. ncbi Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort
    Marie Jeanne Mayaux
    INSERM U569, Hopital de Bicetre, 82 rue du General Leclerc, 94276 Le Kremlin Bicetre Cedex, Paris, France
    J Acquir Immune Defic Syndr 34:338-43. 2003
    ..To determine the percentage and the profile of women with known HIV-1 seropositivity who do not receive the prepartum phase of preventive treatment for maternofetal transmission...
  2. ncbi Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1
    Albert Faye
    Pediatrie Generale, hôpital R Debré, Paris, France
    Clin Infect Dis 39:1692-8. 2004
    ..The clinical impact of early antiretroviral multidrug therapy on the risk of early-onset severe human immunodeficiency virus (HIV) disease has not been evaluated on a large scale...
  3. ncbi Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants
    Albert Faye
    Service d Hémato immunologie, Hĵpital R Debré, Paris, France
    Pediatr Infect Dis J 21:518-25. 2002
    ..To assess tolerance and efficacy of early multitherapy including a protease inhibitor for infants perinatally infected with HIV...
  4. ncbi Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis
    John P A Ioannidis
    Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
    AIDS 18:99-108. 2004
    ....